Lundbeck
HLUN-B.CO
#2771
Rank
$3.70 B
Marketcap
$3.75
Share price
-0.86%
Change (1 day)
N/A
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2022 (TTM): $0.30 B

According to Lundbeck 's latest financial reports the company's current earnings (TTM) are $0.30 B. In 2021 the company made an earning of $0.27 B a decrease over its 2020 earnings that were of $0.32 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$0.30 B10.17%
2021$0.27 B-14.73%
2020$0.32 B-38.5%
2019$0.52 B-33.97%
2018$0.79 B11.84%
2017$0.71 B95.91%
2016$0.36 B-136.98%
2015-$0.99 B-1258.1%
2014$84.76 M-72.43%
2013$0.30 B4.31%
2012$0.29 B-55.26%
2011$0.65 B-9.99%
2010$0.73 B10.56%
2009$0.66 B